Navigation Links
The American Society for Microbiology honors Benjamin P. Howden

Benjamin P. Howden, Ph.D., Austin Health, Melbourne, Australia, has been chosen by the American Society for Microbiology (ASM) to receive a 2011 ICAAC Young Investigator Award. Sponsored by the ASM, this award recognizes an early career scientist for research excellence in microbiology and infectious diseases.

Dr. Howden is an Infectious Diseases Physician and Medical Microbiologist at Austin Health, a leading tertiary hospital in Melbourne, Australia, and Senior Research Fellow in the Department of Microbiology and Immunology at the University of Melbourne. His nominator, M. Lindsay Grayson of Austin Health, calls Dr. Howden "an outstanding infectious diseases physician and microbiologist whose key research focus has been the pathogenesis of serious bacterial infections, particularly Staphylococcus aureus and vancomycin-resistant Entercoccus faecium (VRE)."

Dr. Howden obtained his M.B.B.S. in 1993 from Monash University, and subsequently completed training as an Infectious Diseases Physician (as a Fellow of the Royal Australasian College of Physicians) and Medical Microbiologist (as a Fellow of the Royal College of Pathologists of Australasia). During his doctoral studies at Monash University, Dr. Howden used new comparative and functional genomics approaches to understand in vivo evolution of S. aureus during persistent infection, with a focus on antimicrobial resistance mechanisms. These studies have led to new insights into the molecular basis of vancomycin-intermediate S. aureus (VISA), and have revealed a novel mechanism of reduced linezolid susceptibility in S. aureus.

His most recent research, based on the results of large-scale comparative genomics, has uncovered an important link between antimicrobial resistance and virulence in S. aureus. He is one of the leaders of an integrated bacterial research program based in the Austin Centre for Infection Research (ACIR) at Austin Health, a program focused on investigating the clinical and molecular aspects of virulence and antimicrobial resistance of the human bacterial pathogens S. aureus and E. faecium.

"Dr. Howden has been extraordinarily productive, and has made major contributions to our understanding of the genetic basis of this phenomenon," says a supporter of his nomination, John Turnidge of Women's and Children's Hospital, Adelaide, South Australia. With 45 peer reviewed publications that have attracted over 700 citations, Dr. Howden is using his position as an active physician and medical microbiologist to develop a sophisticated clinical and molecular research program that is addressing some of the most pressing issues in human infectious diseases medicine. The second supporter of his nomination, Roy Robins-Browne of The University of Melbourne, expands on Dr. Howden's accomplishments: "he has already received a number of prestigious awards for his professional achievements from such bodies as the Premier of the State of Victoria, Australia, The Royal Australasian College of Physicians, ICAAC, The Australian Society for Antimicrobials (which recently appointed Dr Howden as its vice president), and the Australasian Society for HIV Medicine."

"Without question, Dr. Howden is one of the rising stars in infectious diseases researchboth nationally and internationally," summarizes Dr. Grayson.


Contact: Garth Hogan
American Society for Microbiology

Related biology news :

1. American Well and Numera Join Forces to Integrate Home Monitoring and Telehealth Services
2. USGS research frontiers on fish at the American Fisheries Society Conference
3. Differences in cell response could explain higher rates of hypertension in African-Americans
4. Lack of free play among children is causing harm, say experts in American Journal of Play
5. Protein in the urine spells kidney failure for African-Americans
6. American Society of Human Genetics to host 12th International Congress of Human Genetics
7. Subsistence Economies of Indigenous North American Societies: A Handbook
8. Getting 50-year-old Americans as healthy as Europeans could save Medicare and Medicaid $632 billion by 2050
9. Bizarre insect inbreeding signals an end to males: News tips from the American Naturalist
10. News media registration for American Chemical Society National Meeting Denver, Aug. 28-Sept. 1, 2011
11. Life scientists use novel technique to produce genetic map for African Americans
Post Your Comments:
(Date:11/18/2015)... , Nov. 18, 2015  As new scientific ... children, doctors and other healthcare providers face challenges in ... families and patients. In addition, as more children continue ... a patient,s adulthood and old age. John ... The Children,s Hospital of Philadelphia (CHOP) . ...
(Date:11/17/2015)... , November 17, 2015 ... 19 novembre  2015.  --> Paris , ... --> DERMALOG, le leader de l,innovation biométrique, a ... fois passeports et empreintes sur la même surface de ... passeports et l,autre pour les empreintes digitales. Désormais, un ...
(Date:11/16/2015)... , Nov 16, 2015  Synaptics Inc. ... human interface solutions, today announced expansion of its ... ™ touch controller and display driver integration ... of smartphones. These new TDDI products add to ... (HD resolution), TD4302 (WQHD resolution), and TD4322 (FHD ...
Breaking Biology News(10 mins):
(Date:12/1/2015)... 2015  Symic, a clinical-stage biotherapeutics company developing multiple ... today announced that it has secured $25 million in ... including its lead candidates SB-030 and SB-061. The financing ... by all existing major investors, as well as several ... raised by Symic to over $43 million since being ...
(Date:12/1/2015)... ) has ... Virology and Bacteriology Testing Market: Sales and ... Shares by Test, Innovative Technologies, Competitive Strategies, ... --> ) has announced the ... Bacteriology Testing Market: Sales and Volume Segment ...
(Date:11/30/2015)... -- An interventional radiology technique shows promise for helping morbidly obese ... study being presented today at the annual meeting of the ... --> --> Gastric ... as a way to stop bleeding in emergency situations, but ... treating obesity is new. Mubin Syed , M.D., ...
(Date:11/30/2015)... Nov. 30, 2015 /PRNewswire/ - Zenith Epigenetics Corp. ("Zenith" or ... Norman C.W. Wong to its Board of Directors to ... Zenith with a wealth of experience as co-founder of Resverlogix, ... --> --> Dr. Wong ... board of directors. Zenith,s long standing expertise in epigenetics and ...
Breaking Biology Technology: